Assessing the measure of a new drug: Is survival the only thing that matters?

被引：58
作者：
Sargent, Daniel J. [1 ]
Hayes, Daniel F. [2 ]
机构：
[1] Mayo Clin, Ctr Canc, Div Biostat, Rochester, MN 55905 USA
[2] Univ Michigan, Ctr Comprehens Canc, Breast Oncol Program, Ann Arbor, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 12期
关键词：
D O I：
10.1200/JCO.2007.14.8064
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1922 / 1923
页数：2
相关论文
共 15 条
[1]   Bayesian statistics and the efficiency and ethics of clinical trials [J].
Berry, DA .
STATISTICAL SCIENCE, 2004, 19 (01) :175-187
[2]   Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients [J].
Bruzzi, P ;
Del Mastro, L ;
Sormani, MP ;
Bastholt, L ;
Danova, M ;
Focan, C ;
Fountzilas, G ;
Paul, J ;
Rosso, R ;
Venturini, M .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5117-5125
[3]   Circulating tumor cells versus imaging - Predicting overall survival in metastatic breast cancer [J].
Budd, G. Thomas ;
Cristofanilli, Massimo ;
Ellis, Mathew J. ;
Stopeck, Allison ;
Borden, Ernest ;
Miller, M. Craig ;
Matera, Jeri ;
Repollet, Madeline ;
Doyle, Gerald V. ;
Terstappen, Leon W. M. M. ;
Hayes, Daniel F. .
CLINICAL CANCER RESEARCH, 2006, 12 (21) :6403-6409
[4]  
Burzykowski T., 2005, EVALUATION SURROGATE
[5]   Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer [J].
Burzykowski, Tomasz ;
Buyse, Marc ;
Piccart-Gebhart, Martine J. ;
Sledge, George ;
Carmichael, James ;
Lueck, Hans-Joachim ;
Mackey, John R. ;
Nabholtz, Jean-Marc ;
Paridaens, Robert ;
Biganzoli, Laura ;
Jassem, Jacek ;
Bontenbal, Marijke ;
Bonneterre, Jacques ;
Chan, Stephen ;
Basaran, Gul Atalay ;
Therasse, Patrick .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) :1987-1992
[6]   Progression-free survival is a surrogate for survival in advanced colorectal cancer [J].
Buyse, Marc ;
Burzykowski, Tomasz ;
Carroll, Kevin ;
Michiels, Stefan ;
Sargent, Daniel J. ;
Miller, Langdon L. ;
Elfring, Gary L. ;
Pignon, Jean-Pierre ;
Piedbois, Pascal .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) :5218-5224
[7]   The impact of new chemotherapeutic and agents on survival in a population-based of women with metastatic breast cancer hormone cohort [J].
Chia, Stephen K. ;
Speers, Caroline H. ;
D'yachkova, Yulia ;
Kang, Anna ;
Malfair-Taylor, Suzanne ;
Barnett, Jeff ;
Coldman, Andy ;
Gelmon, Karen A. ;
O'Reilly, Susan E. ;
Olivotto, Ivo A. .
CANCER, 2007, 110 (05) :973-979
[8]  
ELLIS M, 2004, TREATMENT METASTATIS, P1101
[9]   Surrogate end points in clinical trials: Are we being misled? [J].
Fleming, TR ;
DeMets, DL .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) :605-613
[10]  
MILLER K, 2005, P 41 AM SOC CLIN ONC
12